Dan Murray

Dan Murray is an associate in the firm’s Business Law Department and a member of its Private Equity group. He joined Goodwin in 2020.

Dan’s practice focuses primarily on mergers and acquisitions, private equity and venture capital investments, and other general corporate matters in a broad range of industries. Specifically, he has experience representing corporate strategic, search fund and private equity clients in structuring, negotiating, documenting and closing private mergers, acquisitions, and dispositions, including assisting private equity funds with the purchase, ongoing representation and sale of portfolio companies.

• Accel Partners in its investment in Blackpoint Cyber
• Ampersand Capital Partners 
  • in its Series C-2 Preferred Stock and Series B Preferred Stock investments in AnaBios Corporation 
  • in the sale of its portfolio company, Nexcelom Bioscience Holdings, to PerkinElmer
• AnaBios Corporation, a portfolio company of Ampersand Capital Partners, in its acquisition of Cell Systems
• Arranta Bio Holdings in its sale to Recipharm
• Artifact Health in its sale to Iodine Software, a portfolio company of Silversmith Capital Partners and Bain Capital
• B Capital Group Management in various growth equity financing transactions
• DST Global 
  • in its Series C financing investment in GoStudent
  • in its Series B and Series C Preferred Stock investments in CloudWalk
  • in its Series D investment in Checkout Payments Group Limited
• Erbi Biosystems in its sale to EMD Millipore Corporation, an affiliate of Merck Group
• Sound Healthcare Communications in its sale to Medical Knowledge Group 
• GEF Capital Partners in its acquisition of Murf Electric Bikes
• Gemini Investments, an affiliate of DST Global
  • in its Series D-1 Preferred Stock investment in TravelPerk
  • in its Series A Preferred Stock investment in Clara Holdings Limited
  • in its Series B investment in BukuKas
  • in its Series B-1 Preferred Stock investment in Frubana
• Greyhound Capital in its Series D-1 Preferred Stock investment in DriveWealth
• Medical Marketing Solutions Group in its sale to Red Nucleus, a portfolio company of The Riverside Company
• Sequoia Capital Heritage Fund 
  • in its Series B-1 Preferred Stock investment in Genetic Foresight
  • in its investment of Common Stock in Genetic Foresight
• Sequoia Capital Global Equities in its third-party tender offer for shares in ServiceTitan
• TA Associates in the sale of its portfolio company, PetPeople Holdings, to Hollywood Feed
• Thrive Capital Partners in its Series A Preferred Stock investment in Parafin
• WisdomTree in its acquisition of Securrency Transfers 

Prior to law school, Dan had a career in the entertainment industry.

Prior to entering private practice, Dan worked as a special assistant and legal counsel to the General Treasurer and Governor of the State of Rhode Island.